James E. Shields
29Patents
20h-index
10Co-inventors
82Inventor score
Filing activity: Mar 11, 1976 → Aug 4, 1997
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5514646A | Insulin analogs modified at position 29 of the B chain | Human Necessities | 161 | Expired |
| US5700662A | Process for preparing insulin analogs | Human Necessities | 68 | Expired |
| US5691309A | Anti-obesity proteins | Human Necessities | 56 | Expired |
| US5521283A | Anti-obesity proteins | Human Necessities | 48 | Expired |
| US4087390A | Somatostatin analogs and intermediates thereto | Emerging Cross-Sectional Technologies | 40 | Expired |
| US4100117A | Somatostatin analogs and intermediates thereto | Emerging Cross-Sectional Technologies | 39 | Expired |
| US4093574A | Somatostatin analogs and intermediates thereto | Emerging Cross-Sectional Technologies | 38 | Expired |
| US5552522A | Anti-obesity proteins | Human Necessities | 36 | Expired |
| US5532336A | Anti-obesity proteins | Human Necessities | 36 | Expired |
| US5594104A | Anti-obesity proteins | Human Necessities | 29 | Expired |
| US5580954A | Anti-obesity proteins | Human Necessities | 29 | Expired |
| US5569744A | Anti-obesity proteins | Human Necessities | 25 | Expired |
| US5567678A | Anti-obesity proteins | Human Necessities | 23 | Expired |
| US5574133A | Anti-obesity proteins | Human Necessities | 23 | Expired |
| US5563243A | Anti-obesity proteins | Human Necessities | 23 | Expired |
| US5569743A | Anti-obesity proteins | Human Necessities | 23 | Expired |
| US5563245A | Anti-obesity proteins | Human Necessities | 22 | Expired |
| US5563244A | Anti-obesity proteins | Human Necessities | 22 | Expired |
| US5567803A | Anti-obesity proteins | Human Necessities | 22 | Expired |
| US5605886A | Anti-obesity proteins | Human Necessities | 21 | Expired |
| US5525705A | Anti-obesity proteins | Human Necessities | 20 | Expired |
| US5851995A | Anti-obesity proteins | Human Necessities | 9 | Expired |
| US4062816A | D-Ala.sup.5 -somatostatin and intermediates thereto | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4061626A | Somatostatin analogs and intermediates thereto | Emerging Cross-Sectional Technologies | 7 | Expired |
| US4076659A | L-Val.sup.10 -somatostatin and intermediates thereto | Emerging Cross-Sectional Technologies | 5 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.